Microenvironmental IL13 Rα2 Expression and Enable Extracellular Vesicle-Mediated Antigen Transfer in Glioblastoma
- 1Division of Neurosurgery, Department of Surgery, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA 91010, USA
- 2Department of Hematology and Hematopoietic Cell Transplantation, T Cell Therapeutics Research Laboratories, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA 91010, USA
- 3Light Microscopy Core, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA 91010, USA
Abstract
Background/Objectives: Interleukin-13 receptor alpha 2 (IL13Rα2), expressed in more than 75% of glioblastomas (GBM), is a promising chimeric antigen receptor (CAR) T cell target. We investigated how microenvironmental stresses regulate IL13Rα2 expression and whether extracellular vesicle (EV)-mediated antigen transfer modulates CAR T cell killing. Methods: Patient-derived brain tumor and other GBM cell lines were exposed to hypoxia, desferrioxamine (DFO), or reduced fetal bovine serum (FBS). Western blotting assessed IL13Rα2 expression and recovery following reoxygenation. Fluorescence imaging evaluated EV interactions with recipient cells, and cytotoxicity assays assessed CAR T cell killing. Results: Hypoxia and DFO markedly suppressed IL13Rα2 expression. Exposure to 1% oxygen for 48 h reduced protein levels by 40–70%; expression recovered to near-baseline levels within 48 h of reoxygenation. Reduced FBS concentrations for 48 h also decreased IL13Rα2 expression compared with 10% FBS. Findings suggested potential contributions from ubiquitin-dependent degradation and transcriptional mechanisms. IL13Rα2-expressing EVs showed a slight increase under hypoxia. Fluorescence imaging confirmed that IL13Rα2-containing EVs attached to or entered recipient GBM cells within hours. EV-mediated antigen transfer increased CAR T cell killing by 3–5%. Conclusions: Hypoxia and nutrient availability dynamically regulate IL13Rα2 expression, while EVs can transfer the antigen between GBM cells and modestly enhance CAR T cell killing. These findings highlight reversible antigen modulation and EV-mediated antigen redistribution as mechanisms that could inform strategies to overcome antigen escape and improve immune targeting in GBM.
Related
- Effects of panitumumab on the proteome of treated EGFRvIII glioblastoma cells and on their extracellular vesicles
- Microglia-derived Small Extracellular Vesicles Promote Bone Marrow Monocyte Expansion and Recruitment in Glioblastoma.
- Stromal CCL2/CXCL10/SPARC axes drive pro-tumor CHI3L1 expression for microenvironmental modulation in pancreatic cancer progression and therapeutic innovation
- miR-770 as a potential regulator of DNA methylation-related gene expression in glioblastoma: from in silico prediction to functional validation
- Radiation therapy synergizes with mRNA vaccination to overcome microglia-mediated suppression of dendritic cell migration and T cell priming in glioblastoma
BibTeX
@article{wang2026microenvironmental,
title = {{Microenvironmental IL13 Rα2 Expression and Enable Extracellular Vesicle-Mediated Antigen Transfer in Glioblastoma}},
author = {Yujun Wang and Ryan Urak and Clara Chen and Martha Salas and Christine Brown and Lisa Anne Feldman},
journal = {Cancers},
year = {2026},
month = oct,
doi = {10.3390/cancers18213513},
url = {https://www.mdpi.com/2072-6694/18/21/3513},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Microenvironmental IL13 Rα2 Expression and Enable Extracellular Vesicle-Mediated Antigen Transfer in Glioblastoma
AU - Yujun Wang
AU - Ryan Urak
AU - Clara Chen
AU - Martha Salas
AU - Christine Brown
AU - Lisa Anne Feldman
PY - 2026
DA - 2026/10/31
JO - Cancers
DO - 10.3390/cancers18213513
UR - https://www.mdpi.com/2072-6694/18/21/3513
AB - Background/Objectives: Interleukin-13 receptor alpha 2 (IL13Rα2), expressed in more than 75% of glioblastomas (GBM), is a promising chimeric antigen receptor (CAR) T cell target. We investigated how microenvironmental stresses regulate IL13Rα2 expression and whether extracellular vesicle (EV)-mediated antigen transfer modulates CAR T cell killing. Methods: Patient-derived brain tumor and other GBM cell lines were exposed to hypoxia, desferrioxamine (DFO), or reduced fetal bovine serum (FBS). Western blotting assessed IL13Rα2 expression and recovery following reoxygenation. Fluorescence imaging evaluated EV interactions with recipient cells, and cytotoxicity assays assessed CAR T cell killing. Results: Hypoxia and DFO markedly suppressed IL13Rα2 expression. Exposure to 1% oxygen for 48 h reduced protein levels by 40–70%; expression recovered to near-baseline levels within 48 h of reoxygenation. Reduced FBS concentrations for 48 h also decreased IL13Rα2 expression compared with 10% FBS. Findings suggested potential contributions from ubiquitin-dependent degradation and transcriptional mechanisms. IL13Rα2-expressing EVs showed a slight increase under hypoxia. Fluorescence imaging confirmed that IL13Rα2-containing EVs attached to or entered recipient GBM cells within hours. EV-mediated antigen transfer increased CAR T cell killing by 3–5%. Conclusions: Hypoxia and nutrient availability dynamically regulate IL13Rα2 expression, while EVs can transfer the antigen between GBM cells and modestly enhance CAR T cell killing. These findings highlight reversible antigen modulation and EV-mediated antigen redistribution as mechanisms that could inform strategies to overcome antigen escape and improve immune targeting in GBM.
SN - 2072-6694
ER -